Clincosm LogoSign in Get a demo

Polycythemia Vera

Showing 26 - 50 of 106
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myelofibrosis, Polycythemia Vera Trial in United States (TGR-1202, ruxolitinib)

Active, not recruiting
  • Myelofibrosis
  • Polycythemia Vera
  • Phoenix, Arizona
  • +4 more
Jun 20, 2022

Myeloproliferative Tumor, Essential Thrombocythemia, JAK2 Mutation Trial in Ottawa (Apixaban 2.5 MG Oral Tablet [ELIQUIS],

Recruiting
  • Myeloproliferative Neoplasm
  • +5 more
  • Apixaban 2.5 MG Oral Tablet [ELIQUIS]
  • Aspirin 81 mg
  • Ottawa, Ontario, Canada
    The Ottawa Hospital
Apr 19, 2022

Polycythemia Vera Trial in India, United States (PTG-300, Placebo)

Active, not recruiting
  • Polycythemia Vera
  • Phoenix, Arizona
  • +15 more
Apr 12, 2022

Primary Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia Trial in Toronto (Observational)

Recruiting
  • Primary Myelofibrosis
  • +9 more
  • Observational
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Apr 11, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aplastic Anemia Trial in Philadelphia (procedure, drug, radiation)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +15 more
  • Hematopoietic Cell Transplantation
  • +7 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Apr 1, 2022

Polycythemia Vera Trial in Korea, Republic of, Malaysia (PTG-300)

Active, not recruiting
  • Polycythemia Vera
  • Incheon, Korea, Republic of
  • +7 more
Mar 8, 2022

Polycythemia Vera Trial (Ruxolitinib)

Available
  • Polycythemia Vera
  • (no location specified)
Mar 7, 2022

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +125 more
  • tetanus-CMV fusion peptide vaccine
  • laboratory biomarker analysis
  • Duarte, California
    City of Hope Medical Center
Feb 28, 2022

Primary Myelofibrosis, Polycythemia Vera, Post-Essential Thrombocythemia Myelofibrosis Trial in Worldwide (RO7490677,

Completed
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Phoenix, Arizona
  • +22 more
Dec 7, 2021

Chronic Myelomonocytic Leukemia, Chronic Myeloid Leukemia, Polycythemia Vera Trial in Houston (Imatinib Mesylate (Gleevec))

Completed
Has Results
  • Chronic Myelomonocytic Leukemia
  • +4 more
  • Imatinib Mesylate (Gleevec)
  • Houston, Texas
    UT MD Anderson Cancer Center
Dec 7, 2021

Polycythemia Vera Trial in Worldwide (Idasanutlin)

Terminated
Has Results
  • Polycythemia Vera
  • Phoenix, Arizona
  • +10 more
Dec 7, 2021

Polycythemia Vera Trial in London, Oxford (Ruxolitinib, Hydroxycarbamide, Interferon-Alpha)

Recruiting
  • Polycythemia Vera
  • London, United Kingdom
  • +1 more
Nov 29, 2021

Polycythemia Vera Trial in Worldwide (Best Available Therapy, Ruxolitinib)

Completed
Has Results
  • Polycythemia Vera
  • Herston, Queensland, Australia
  • +47 more
Jun 29, 2021

Chronic Phase Myelofibrosis, Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Boston, Bronx, New

Completed
Has Results
  • Chronic Phase Myelofibrosis
  • +3 more
  • Boston, Massachusetts
  • +2 more
May 27, 2021

Polycythemia Vera Trial in Worldwide (Pegylated-Proline-interferon alpha-2b, Best available therapy (BAT))

Completed
  • Polycythemia Vera
  • Pegylated-Proline-interferon alpha-2b
  • Best available therapy (BAT)
  • Graz, Austria
  • +46 more
May 27, 2021

Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With

Active, not recruiting
  • Adult Acute Lymphoblastic Leukemia in Remission
  • +46 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Feb 10, 2021

Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in Worldwide

Completed
Has Results
  • Primary Myelofibrosis
  • +4 more
  • Scottsdale, Arizona
  • +21 more
Jan 18, 2021

Essential Thrombocythemia, Polycythemia Vera Trial in Boston (Ruxolitinib)

Not yet recruiting
  • Essential Thrombocythemia
  • Polycythemia Vera
  • Boston, Massachusetts
  • +2 more
Nov 24, 2020

Polycythaemia Vera and Essential Thrombocythaemia: Influence on

Completed
  • Polycythemia Vera
  • Thrombocythemia, Essential
  • No cytoreductive vs cytoreductive drugs
  • Geneva, Switzerland
  • +1 more
Nov 9, 2020

Polycythemia Vera Trial in Oklahoma City (Erlotinib)

Terminated
Has Results
  • Polycythemia Vera
  • Oklahoma City, Oklahoma
    University of Oklahoma Health Sciences Center
Aug 7, 2020

Essential Thrombocythemia, Primary Myelofibrosis, Fibrotic Stage, Primary Myelofibrosis, Prefibrotic Stage Trial in Doha

Terminated
  • Essential Thrombocythemia
  • +3 more
  • Diagnostic (18F-FLT PET/CT)
  • Doha, Qatar
    National Center for Cancer Care & Research (NCCCR)
Aug 10, 2020

Polycythemia Vera Trial in Worldwide (KRT-232, Ruxolitinib)

Unknown status
  • Polycythemia Vera
  • Birmingham, Alabama
  • +15 more
Jul 30, 2020

Endoplasmic Reticulum Stress and Resistance to Treatments in

Completed
  • Polycythemia Vera
  • Essential Thrombocythemia
  • RNA sample of total leukocytes before start of treatment
  • Angers, France
  • +6 more
Jun 18, 2020

Polycythemia Vera, Essential Thrombocythemia Trial in Worldwide (Momelotinib)

Terminated
  • Polycythemia Vera
  • Essential Thrombocythemia
  • Scottsdale, Arizona
  • +14 more
Apr 14, 2020

Primary Myelofibrosis, Thrombocytosis, Essential Thrombocythemia Trial in Worldwide (LDE225, INC424)

Completed
Has Results
  • Primary Myelofibrosis
  • +9 more
  • Camperdown, New South Wales, Australia
  • +17 more
Apr 3, 2020